Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study

Progestin and breast cancer risk: a systematic review

(2015) Marsha Samson et al.   BREAST CANCER RESEARCH AND TREATMENT

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Reproductive risk factors and breast cancer subtypes: a review of the literature

(2014) Kristin N. Anderson et al.   BREAST CANCER RESEARCH AND TREATMENT

Oral Contraceptives and Breast Cancer Risk Overall and by Molecular Subtype Among Young Women

(2014) E. F. Beaber et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Recent Oral Contraceptive Use by Formulation and Breast Cancer Risk among Women 20 to 49 Years of Age

(2014) E. F. Beaber et al.   CANCER RESEARCH

Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review

(2013) J. M. Gierisch et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

(2012)   LANCET ONCOLOGY

Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer

(2011) A. I. Phipps et al.   JNCI-Journal of the National Cancer Institute

Oral Contraceptive Use and Estrogen/Progesterone Receptor-Negative Breast Cancer among African American Women

(2010) L. Rosenberg et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Oral Contraceptive Use and Breast Cancer: A Prospective Study of Young Women

(2010) D. J. Hunter et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Use of Four Biomarkers to Evaluate the Risk of Breast Cancer Subtypes in the Women's Contraceptive and Reproductive Experiences Study

(2010) H. Ma et al.   CANCER RESEARCH

Multiple imputation using chained equations: Issues and guidance for practice

(2010) Ian R. White et al.   STATISTICS IN MEDICINE

Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years

(2009) J. M. Dolle et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Breast Cancer Receptor Status: Do Results from a Centralized Pathology Laboratory Agree with SEER Registry Reports?

(2009) H. Ma et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

(2008) Inger Kristin Larsen et al.   EUROPEAN JOURNAL OF CANCER